Posted by: Thixia | July 1, 2008

risk of secondary progression in MS

 

Factors associated with the risk of secondary progression in multiple sclerosis.

 

Objective

 

To investigate factors associated with the risk of secondary progression in relapsing-remitting onset multiple sclerosis (MS).

 

 

Methods

 

We used Kaplan-Meier survival analyses and a multivariable Cox regression model to estimate the influence of the factors gender, age at disease onset, use of immunomodulatory drugs (IMD), and clinical manifestation at disease onset on the time to secondary progression in a hospital-based cohort of 571 MS patients with a relapsing-remitting onset.

 

 

Results

 

Gender and onset manifestation had no significant influence on the timing of secondary progression. A higher age at disease onset was associated with a shorter time to secondary progression (multivariable hazard ratio per year increase: 1.02, 95% CI:1.01 – 1.03). The use of IMD was associated with a longer time to secondary progression (multivariable hazard ratio: 0.30, 95% CI: 0.15 – 0.61).

 

 

Conclusions

 

The inverse relationship between age at disease onset and onset of secondary progression is in keeping with previous natural history studies. The beneficial effect of IMD treatment on the time to secondary progression should be taken as hypothesis generating rather than as proof of a treatment effect, and needs to be further evaluated in well-designed randomised controlled trials.

 

University Medical Center Groningen,

Neurology.

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

%d bloggers like this: